Alembic Pharmaceuticals Market Cap

Alembic Pharmaceuticals has a market cap or net worth of 149.27 billion as of April 28, 2026. Its market cap has decreased by -14.40% in one year.

Market Cap

149.27B

Enterprise Value

162.69B

Revenue

72.67B

Ranking

n/a

PE Ratio

23.68

Stock Price

760.00

Market Cap Chart

Since September 21, 2011, Alembic Pharmaceuticals's market cap has increased from 9.00B to 149.27B, an increase of 1,558.25%. That is a compound annual growth rate of 21.20%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	150.29B	-9.64%
Dec 31, 2025	166.32B	-20.64%
Dec 31, 2024	209.59B	40.41%
Dec 29, 2023	149.27B	32.55%
Dec 30, 2022	112.61B	-28.56%
Dec 31, 2021	157.62B	-22.43%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Cohance Lifesciences	165.31B
Alivus Life Sciences	128.25B
Eris Lifesciences	188.17B
NATCO Pharma	195.96B
Piramal Pharma	218.39B
Strides Pharma Science	96.96B
Wockhardt	230.30B
Akums Drugs and Pharmaceuticals	81.34B

Market Cap Rankings